A gene-editing technology called CRISPR-cas9 allows scientists to make precise edits in DNA that could lead to new medical therapies, research tools and new crop varieties. This has been called the biggest biotechnology breakthrough in the past 30 or 40 years which could result in the most valuable biotech patents. Scientists also assume CRISPR will earn Nobel Prizes for the scientists who are proved inventors of this technology.
Unfortunately it is not clear who owns the idea. US patent judges will hear oral arguments from high-prestige universities and well-regarded scientists but this is just the first step in a process that’s likely to last through 2017.